MicrobeWorld App


Microbes After Hours


Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email


Featured Image

Featured Video

Ebola Virus explained


ASM House 200X200

ReGenesis (MWV8)



ReGenesis is an award winning science drama produced by Toronto's Shaftesbury Films that centers on the fictitious North American Biotechnology Advisory Commission. NorBAC's special operations team, headed by the brilliant but unpredictable Molecular Biologist Dr. David Sandstrm (Peter Outerbridge) and supported by a cast of forensic specialists and CIA operatives, investigates new strains of disease, genetically modified bacteria, and potential bioterror threats or agents. In essence, the show is about microbial forensics and the lives of the people who work in and around the lab.

ReGenesis is also one of the first dramas to feature full media convergence and was recently awarded with the 2007 International Emmy in the Interactive Program category and the 2006 Gemini Award for Best Cross Platform Project. Visitors to the website can tour the NorBAC laboratory, partake in the laboratory's problem solving, and get insight into each episode's health and science issues by getting the "Facts Behind the Fiction" and ""Science and Society" fact sheets, where episodic drama is analyzed by leading scientists compliments of the Ontario Genomics Institute.

The series launched in the US in September 2007 and can be seen on television stations affiliated with ABC, Belo, CBS, Granite, Fox, Hearst, LIN TV, and the Tribune and Young group. ReGenesis is set to become the first complete, original HDTV series offered for weekend syndication. To watch ReGenesis in your area, please check your local listings.

Alternate File Types

.mov (58 megs)
.m4v (iPod, 134 megs)
.m4v (iPhone, 82 megs)
.3gp (13 megs)
PSP (Play Station Portable, 40 megs)


Comments (0)

Collections (0)

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use